Protara Therapeutics Inc [TARA] stock prices are up 11.78% to $5.6 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TARA shares have gain 6.87% over the last week, with a monthly amount glided 4.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Protara Therapeutics Inc [NASDAQ: TARA] stock has seen the most recent analyst activity on January 07, 2026, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $24. Previously, Scotiabank started tracking the stock with Sector Outperform rating on April 16, 2025, and set its price target to $12. On March 14, 2025, Cantor Fitzgerald initiated with a Overweight rating. H.C. Wainwright initiated its recommendation with a Buy and recommended $40 as its price target on June 04, 2021. Oppenheimer started tracking with a Outperform rating for this stock on February 17, 2021, and assigned it a price target of $43. In a note dated October 19, 2020, Cowen initiated an Outperform rating and provided a target price of $50 on this stock.
The stock price of Protara Therapeutics Inc [TARA] has been fluctuating between $2.77 and $7.82 over the past year. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Protara Therapeutics Inc [NASDAQ: TARA] shares were valued at $5.6 at the most recent close of the market. An investor can expect a potential return of 114.29% based on the average TARA price forecast.
Analyzing the TARA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.35 and Total Capital is -0.44. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Protara Therapeutics Inc [NASDAQ:TARA]’s Current Ratio is 13.69. As well, the Quick Ratio is 13.69, while the Cash Ratio is 1.27.
Transactions by insiders
Recent insider trading involved Levy Richard S, Director, that happened on May 14 ’25 when 20000.0 shares were purchased. Chf Scientific Operations Off, Zummo Jacqueline completed a deal on Mar 26 ’25 to sell 21224.0 shares. Meanwhile, Officer Zummo Jacqueline bought 21224.0 shares on Mar 26 ’25.
